Delivery Order SPE2DB22D2007-SPE2DB24FJ3AG
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $11,213.60, is a firm fixed price delivery order with a period of performance through July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,595.00 and an ultimate completion date of June 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract valued at $5,586.06. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $5,038.00, is for the delivery of BENLYSTA 400 MG VIALS to the U.S. Defense Logistics Agency (DLA). The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a period ending on July 31, 2024. The firm-fixed-price contract has a ceiling value of $8,379.09. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the U.S. Defense Department's Medical Supply Chain agency. The $16,758.18 firm fixed-price delivery order contract has a completion date of May 6, 2024 and was awarded on April 15, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,275.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564318948 units of BENLYSTA 120 MG VIALS, with a period of performance through May 9, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the main...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,557 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to military treatment programs and facilities...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the provision of BENLYSTA 400 MG vials. The contract has a ceiling value of $5,038.00 and a completion date of June 25, 2024. This award is issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 400 mg vials of the pharmaceutical product BENLYSTA. The $2,519.00 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 30, 2024, with a completion date of May 21, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The company has a...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ3AGDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The $5,038.00 firm fixed price delivery order has a completion date of June 25, 2024 and was awarded on June 3, 2024. This contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain capabilities to efficiently fulfill government medical product requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 6/3/24 |